PARP inhibition has been demonstrated to inhibit checkpoint inhibition in MYCN-dependent NB cells, causing progression through the cell cycle despite DNA damage and ultimately mitotic catastrophe and apoptosis [16, 37]. Here, PARP1 is linked to neuroblastoma.